Moreover, case-control and cohort studies have demonstrated that individuals with higher levels of insulin or C-peptide (indirect insulin measure) are at higher risk for developing obesity-related cancers including breast, endometrial, colorectal, pancreatic, liver, ovarian and gastric cancers compared to individuals with low levels of these factors (reviewed in [75]). The gene discussed is INS; the disease is cancer.